Exhibit 13.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Titan Medical Inc. (the “Company”) on Form 20-F for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Paul Cataford, Interim President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

March 24, 2022 /s/ Paul Cataford 
  Paul Cataford
  Interim President and Chief Executive Officer
(Principal Executive Officer)

 

A signed original of this written statement required by Section 906 has been provided to Titan Medical Inc. and will be retained by Titan Medical Inc. and furnished to the Securities and Exchange Commission or its staff upon request.